Bayer AG’s Q2 2022 Results Show Global Sales Growth Amid China VBP Pressures
Germany-based pharmaceutical giant Bayer AG (VIE: BAYN) released its Q2 2022 financial report, revealing a...
Intellective Biologics Raises Over RMB500m in Series C Financing Round
China-based macromolecule-focused Contract Development and Manufacturing Organization (CDMO) Intellective Biologics (Suzhou) Co., Ltd has reportedly...
MicuRx Pharmaceuticals Completes RMB1.06B IPO for Antibacterial Drug Development
Shanghai-based antibacterial drug developer MicuRx Pharmaceuticals has officially made an initial public offering (IPO) of...
invoX Pharma Extends Tender Offer for F-star Therapeutics to September 19
invoX Pharma Ltd, a UK-based subsidiary of China’s Sino Biopharmaceutical Ltd (HKG: 1177), announced that...
Merck Launches Prevymis, a Non-Nucleoside CMV Inhibitor, in China
US pharmaceutical giant Merck Sharp & Dohme (MSD, NYSE: MRK) announced the commercial launch of...
BeiGene’s Q2 2022 Revenues Surge 120%, Brukinsa Sales Triple
BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235) reported its financial results for Q2 2022, recording...
Innovent Biologics and Sanofi Announce License Deal for Drug Development in China
China-based biotech firm Innovent Biologics Inc. (HKG: 1801) and France’s Sanofi SA (NASDAQ: SNY) have...
Eli Lilly Reports First Quarterly Revenue Dip in Two Years, China Sales Plunge
US-based Eli Lilly & Co. (NYSE: LLY) released its Q2 2022 financial report, revealing a...
Novo Nordisk’s H1 2022 Results Show Strong Global Sales Growth, China Sales Dip
Denmark-based Novo Nordisk (NYSE: NVO) released its H1 2022 financial results, reporting a 14% year-on-year...
Shanghai Pharmaceuticals Partners with HKSTP and Shanghai Biomedicine Fund on R&D Collaboration
Shanghai Pharmaceuticals (HKG: 2607, SHA: 601607), a leading Chinese pharmaceutical company, has entered into a...
Zhongsheng Pharmaceutical Completes Phase I Study of RAY1216 for COVID-19 Treatment
China-based Guangdong Zhongsheng Pharmaceutical Co., Ltd (SHE: 002317) announced the completion of subject enrollment and...
CSPC Pharmaceutical’s rhTNK-tPA Meets Primary Endpoint in Stroke Study
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) announced that the Phase III clinical study for...
HeNan Genuine Biotech Files for IPO to Fund Azvudine Commercialization
China-based HeNan Genuine Biotech Co., Ltd has filed for an initial public offering (IPO) with...
Innovent Biologics’ Q2 2022 Revenues Surpass RMB 1 Billion, Seven Products Approved
Innovent Biologics Inc. (HKG: 1801) released its Q2 2022 financial report, with product revenues exceeding...
Hybio Pharmaceutical’s HY3000 Nasal Spray for COVID-19 Enters NMPA Review
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) announced that its clinical trial filing for HY3000...
GenScript’s Legend Biotech Appoints Three New Directors to Board
Hong Kong-based Contract Research Organization (CRO) GenScript Biotech Corporation (HKG: 1548) announced that its subsidiary...
Boehringer Ingelheim Wins Patent Infringement Ruling Against HEC Over Trajenta
The China National Intellectual Property Administration (CNIPA) has ruled in favor of German pharmaceutical giant...
Zelgen’s Jacktinib Hits Phase IIb Endpoint in Myelofibrosis Study
Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) announced the successful completion of a pivotal Phase...
Wision A.I.’s Polyp Detection Software Secures NMPA Approval for Colonoscopy Use
The National Medical Products Administration (NMPA) has approved China-based Wision A.I.’s intestinal polyp electronic colonoscopy...
Ethicon’s Hemostatic Granules Win NMPA Approval for Endoscopic Surgery Use
The National Medical Products Administration (NMPA) has granted marketing approval to U.S. medical device firm...